In this investigation, we have observed that individuals with Parkinson’s disease (PD) who experienced cognitive impairment exhibited elevated levels of serum Lp-PLA2 activity in comparison to PD patients with intact cognitive function. This evidence concerns the gene PLA2G7 and Cognitive impairment.